Ruijin Hospital

This study tests whether adding two drugs (camrelizumab and apatinib) to standard chemotherapy before surgery can help people with advanced stomach or gastroesophageal junction cancer. About 80 participants will receive the treatment, and researchers will check how many have no c…

This study tests a new type of brain stimulation (HD-ctACS) for people with depression that hasn't improved with standard treatments. Ten participants will receive both the real stimulation and a sham (fake) version at different times to compare effects. The goal is to see if thi…

This study tests a new ultrasound-based method called Ultrasonic Flow Ratio (UFR) to see if it can accurately identify significant blockages in heart arteries. Researchers will compare UFR results to the standard fractional flow reserve (FFR) test in 112 adults with suspected hea…

This study tests a new, non-invasive brain stimulation method called Temporal Interference Stimulation (TIS) in 40 people with early-stage Alzheimer's disease. Half will receive real stimulation and half a sham (fake) treatment for 2 weeks. Researchers will measure changes in mem…

This study looks back at the medical records of 102 adults with B-cell acute lymphoblastic leukemia to see how well the drug inotuzumab ozogamicin worked. The researchers are checking how many patients achieved remission and how long they lived. No new treatments are given—this i…